A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.
Final adult height of patients who received hematopoietic cell transplantation in childhood.
Duration of immunosuppressive treatment for chronic graft-versus-host disease.
Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia.
Bone Marrow Transplantation
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease.
Biol. Blood Marrow Transplant., Nov;18(11):1649-55 (2012)
Clinical benefit of response in chronic graft-versus-host disease.
Biol. Blood Marrow Transplant., Oct;18(10):1517-24 (2012)
Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia.
Blood., Jun;119(25):6155-61 (2012)
Success of allogeneic marrow transplantation for children with severe aplastic anaemia.
Br. J. Haematol., Jul;158(1):120-8 (2012)
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
Biol. Blood Marrow Transplant., Aug;18(8):1150-63 (2012)
Secondary treatment of acute graft-versus-host disease: a critical review.
Biol. Blood Marrow Transplant., Jul;18(7):982-8 (2012)
Transplantation for AML in children.
Biol. Blood Marrow Transplant., Jan;18(1 Suppl):S33-9 (2012)
Validation of measurement scales in ocular graft-versus-host disease.
Ophthalmology., Mar;119(3):487-93 (2012)
Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation.
J. Clin. Oncol., Jan;30(1):71-7 (2012)
Treatment of chronic graft-versus-host disease: Past, present and future.
Korean J Hematol., Sep;46(3):153-63 (2011)
How I conduct a comprehensive chronic graft-versus-host disease assessment.
Blood., Sep;118(10):2679-87 (2011)
Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.
Biol. Blood Marrow Transplant., Dec;17(12):1833-40 (2011)
Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.
Blood., Aug;118(5):1421-8 (2011)
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation.
Blood., Jul;118(2):456-63 (2011)
A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.
Biol. Blood Marrow Transplant., Nov;17(11):1619-29 (2011)